Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers.

ABSTRACT:

Purpose

Preemptive pharmacogenetic testing aims to optimize medication use by having genetic information at the point of prescribing. Payers' decisions influence implementation of this technology. We investigated US payers' knowledge, awareness, and perspectives on preemptive pharmacogenetic testing.

Methods

A qualitative study was conducted using semistructured interviews. Participants were screened for eligibility through an online survey. A blended inductive and deductive approach was used to analyze the transcripts. Two authors conducted an iterative reading process to code and categorize the data.

Results

Medical or pharmacy directors from 14 payer organizations covering 122 million US lives were interviewed. Three concept domains and ten dimensions were develope

SUBMITTER: Keeling NJ 

PROVIDER: S-EPMC5920773 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature